Controlled Substances Act | PMP Center of Excellence

Search

Controlled Substances Act

Prescription drugs: state monitoring programs may help to reduce illegal diversion

Publication Date:

2002

Read report

Tags: case investigation, Controlled Substances Act, diversion, government reports, PMP data, PMP impact, PMP operations, regulatory agencies, state comparisons, testimony

Prescription drug monitoring programs

Author:

Miller, M., Brown, R.

Publication Date:

2007

Publication:

American Family Physician. 75(6), 810-811

Read article.

Tags: access to treatment, addiction, Controlled Substances Act, diversion, editorials, epidemiology, journal articles, PMP impact

Monitoring opioid adherence in chronic pain patients: tools, techniques, and utility

Author:

Manchikanti, L., Atluri, S., Trescot, A. M., Giordano, J.

Publication Date:

2008

Publication:

Pain Physician, 11:S155-S180.

Read abstract.

Read article.

Tags: addiction, chilling effect, controlled substance agreements, Controlled Substances Act, journal articles, opioid abuse, pain management, patient adherence monitoring, PMP comparisons, PMP data, PMP impact, screening tests, urinalysis

National All Schedules Prescription Electronic Reporting Act (NASPER): balancing substance abuse and medical necessity

Author:

Manchikanti, L., Brown, K.R., Singh, V.

Publication Date:

2002

Publication:

Pain Physician. 5(3):294-319.

Read abstract.

Read article.

Tags: addiction, balancing patient care and drug control, benzodiazepines, Controlled Substances Act, diversion, EDT, effectiveness of prescription control, history of substance abuse, hydrocodone, journal articles, MCPPs, methadone, NASPER, opioid abuse, pain management, PMP data, pseudoaddiction, psychiatric disorders, state comparisons, undertreatment of pain